Moleculin Biotech MBRX
NASDAQ MBRX
$6.16 -0.03 (-0.47%)
As of: Oct 21, 2026 · 3:18 PM EDT

Moleculin Biotech (MBRX) Total Debt (2015 - 2017)

Updated

Moleculin Biotech (MBRX) reported Total Debt of $108,000 for Q1 2017, down 82.4% from $615,000 a year earlier and down 63.5% from the prior quarter.

Analysis

Moleculin Biotech (MBRX) Total Debt (2015 - 2017) Analysis & Trends

At the end of FY2016, Moleculin Biotech posted Total Debt of $296,000, down 34.2% from FY2015.

  • By year, Total Debt came in at $450,000 in FY2015.
  • Per Business Quant data, the three quarters before Q1 2017 came in at $296,000 (Q4 2016), $297,656 (Q3 2016) and $431,644 (Q2 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 70.82 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 63.19 Bn
10 Moleculin Biotech 34.99 Mn 4.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 108,000.00
Dec 31, 2016 296,000.00
Sep 30, 2016 297,656.00
Jun 30, 2016 431,644.00
Mar 31, 2016 615,000.00
Dec 31, 2015 450,000.00
API Access

Moleculin Biotech Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=MBRX&period=max&api_key=YOUR_API_KEY